Analysis of data from 38 studies that enrolled more than 2.7 million women - the largest of its kind - by researchers at the University of British Columbia,
Vancouver Coastal Health Research Institute, and the University of Santiago de
Compostela reveals that regular use of Non Steroidal Anti-Inflammatory Drugs
(NSAIDs) is associated with a 12 per cent relative risk reduction in breast
cancer compared to non-users.